Safety Study of RC010 Inhaled Powder in Healthy Adults
Part of Lungs & breathing clinical trials.
This is an early-stage safety study testing a new inhaled medication called RC010 in healthy volunteers. Researchers want to understand how safe it is, how well people tolerate it, and how the body processes it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old
- Your weight and body composition must be within a healthy range (BMI 19–28, and at least 50 kg if male or 45 kg if female)
- You must be willing to use contraception for 90 days after your last study dose
- You cannot have had a recent respiratory infection (within 6 weeks) or serious lung disease
- You must be able to learn and correctly use an inhaler device
- You cannot smoke, use recreational drugs, or drink excessive alcohol
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a first-in-human study of an investigational drug called HW252001. Healthy volunteers will receive a single dose to see how safe it is and how the body processes it.
This early-phase study tests a new inhaled medication called CPD704 in healthy volunteers. It checks safety and how the body processes the drug.
This study tests whether a new inhaled medication called HSK39004 can help people with COPD breathe better and reduce shortness of breath. You'll receive either the medication or a placebo (inactive powder) and be monitored for safety and effectiveness.
This trial tests the safety of a new inhaled medicine. You must be a healthy nonsmoker, have normal lung function, and agree to avoid certain medications and foods.
This trial tests a new inhaled medication called ICF004 in healthy Chinese adults to see if it is safe and how the body processes it. You can join if you are generally healthy and between 18 and 50 years old.
This is an early-stage safety study testing a new inhaled medication called TRL1068 in people without lung disease. Researchers want to make sure the drug is safe and well-tolerated when breathed in.
Hear when a new IPF trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.